These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Antimicrobial susceptibility of anaerobic and aerobic bacteria isolated from patients with mixed infections in Nicaragua. Cáceres M, Carrera E, Palma A, Berrios G, Weintraub A, Nord CE. Rev Esp Quimioter; 1999 Dec; 12(4):332-9. PubMed ID: 10855012 [Abstract] [Full Text] [Related]
31. [Sensitivity of anaerobic bacteria to therapeutic agents (Zurich 1984)]. Wüst J, Hardegger U. Schweiz Med Wochenschr; 1985 Dec 28; 115(52):1886-90. PubMed ID: 4089587 [Abstract] [Full Text] [Related]
32. [In vitro activity of 10 antibiotics including pristinamycin and its two components (RP 12536 and 27404) against strict anaerobes]. Dubreuil L, Houcke I, Singer E. Pathol Biol (Paris); 1998 Feb 28; 46(2):147-52. PubMed ID: 9769928 [Abstract] [Full Text] [Related]
34. [Gram-positive, catalase negative cocci isolated from clinical material--identification and drug sensitivity of strains]. Rokosz A, Rafałowska K, Lipnicki D. Przegl Epidemiol; 1996 Feb 28; 50(3):265-72. PubMed ID: 8927737 [Abstract] [Full Text] [Related]
35. Antibiotic resistance among anaerobic Gram-negative bacilli: lessons from a French multicentric survey. Behra-Miellet J, Calvet L, Mory F, Muller C, Chomarat M, Bézian MC, Bland S, Juvenin ME, Fosse T, Goldstein F, Jaulhac B, Dubreuil L. Anaerobe; 2003 Jun 28; 9(3):105-11. PubMed ID: 16887696 [Abstract] [Full Text] [Related]
36. Comparative in vitro activity of REP3123 against Clostridium difficile and other anaerobic intestinal bacteria. Citron DM, Warren YA, Tyrrell KL, Merriam V, Goldstein EJ. J Antimicrob Chemother; 2009 May 28; 63(5):972-6. PubMed ID: 19240076 [Abstract] [Full Text] [Related]
37. Use of the E-test for determining antimicrobial susceptibility of anaerobic bacteria. Piérard D, De Meyer A, Rosseel P, Lauwers S. Pathol Biol (Paris); 1996 May 28; 44(5):358-62. PubMed ID: 8758476 [Abstract] [Full Text] [Related]
38. [Necrotizing soft tissue infections: role of the localization for the antibiotic management]. Wattel F, Mathieu D, Neut C, Dubreuil L, Cesari JF, Favory R. Bull Acad Natl Med; 2004 May 28; 188(3):473-86; discussion 486-90. PubMed ID: 15584657 [Abstract] [Full Text] [Related]
39. [Susceptibility of clinical strains of gram-positive bacteria to selected beta-lactam antibiotics]. Sawicka-Grzelak A, Rokosz A. Med Dosw Mikrobiol; 1998 May 28; 50(1-2):69-76. PubMed ID: 9857616 [Abstract] [Full Text] [Related]
40. Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients. Worlitzsch D, Rintelen C, Böhm K, Wollschläger B, Merkel N, Borneff-Lipp M, Döring G. Clin Microbiol Infect; 2009 May 28; 15(5):454-60. PubMed ID: 19196263 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]